l. rhamnosus e/n strain

Poland

Drugs containing this active substance

  • LAKCID

    The medicinal product is used to normalize intestinal microflora, especially after antibiotic therapy. It is intended for the supportive treatment of pseudomembranous colitis, the prevention of traveler's diarrhea, and as support during and after antibiotic treatment.

    Form: capsules, hard

    Active substance Dosage
    lactobacillus rhamnosus rods 100 %
    l. rhamnosus oxy strain 20 %
    l rhamnosus pen strain 40 %
    l. rhamnosus e/n strain 40 %

    ATC: A07FA

    Manufacturer: BIOMED-LUBLIN Serum and Vaccines Manufacturing Company Joint-Stock Company